Grant opportunity
Advancing Innovation in Accelerated Cancer Diagnosis
Funding for clinical validation and evaluation of technologies and devices that can accelerate earlier cancer diagnosis.
- Funder
- Innovate UK and Office for Life Sciences
- Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time
- Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time: Oct 28, 2026
- Award
- Up to GBP 25.4 million available across the competition
- Applicant
- Eligible UK applicants developing early cancer diagnostic technologies or devices and meeting the business, collaboration and clinical-validation rules in the full competition guidance.
- Discipline
- Cancer Diagnostics and Health Technology
- Region
- United Kingdom
- Posted
- Aug 22, 2026
Call summary
Overview
The Office for Life Sciences Cancer Healthcare Goals programme will invest in promising diagnostic innovations that are ready for rigorous clinical validation and evaluation.
Who can apply
Applicants must meet the detailed UK registration, project stage, collaboration and clinical requirements that apply when the competition opens.
What it supports
- Early cancer detection
- Diagnostic technologies
- Clinical validation
- Medical devices
Funding and duration
- Up to GBP 25.4 million is allocated across the competition
- Project ceilings and intervention rates are set out in the full official guidance
Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time
Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time: Oct 28, 2026
How to apply
Review the official competition page when it opens on 1 September and submit through the Innovate UK application system by the stated deadline.
Call details
Source-based overview
The competition is intended for technologies with a credible route through clinical validation toward adoption. Applicants should wait for and follow the full official competition brief before finalising a proposal.
Eligibility
Applicants must meet the detailed UK registration, project stage, collaboration and clinical requirements that apply when the competition opens.
Funding and benefits
Up to GBP 25.4 million is allocated across the competition
Project ceilings and intervention rates are set out in the full official guidance
Themes and supported activities
Early cancer detection
Diagnostic technologies
Clinical validation
Medical devices
Deadline and timeline
Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time: Upcoming call opens 1 September and closes 28 October 2026 at 11:00 UK time: Oct 28, 2026.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Review the official competition page when it opens on 1 September and submit through the Innovate UK application system by the stated deadline.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.